The largest database of trusted experimental protocols

Multi ethnic global array

Manufactured by Illumina
Sourced in United States

The Multi-Ethnic Global Array (MEGA) is a high-throughput microarray platform designed for the comprehensive genetic analysis of diverse human populations. It is a robust and versatile tool for researchers to explore genetic variations across a broad range of ancestral backgrounds.

Automatically generated - may contain errors

17 protocols using multi ethnic global array

1

Genetic Diversity of Kenyan Ethnic Groups

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected DNA and demographic information from a total of 572 individuals from Turkana, Samburu, Rendille, and Waso Borana and successfully genotyped 376 of these individuals on Illumina’s Multi-Ethnic Global Array (Table 1; Table S1). For each ethnolinguistic group, we sampled individuals from at least two clans. Data collection occurred across northern Kenya from October 2016 – October 2017. For each participant, a DNA sample was taken in the form of saliva or cheek swab; the saliva was collected in an Oragene OG-500 DNA collection kit. In addition to collecting a DNA sample, a questionnaire was administered to each participant to acquire demographic information; this information included, for example, natal and post-marital clan affiliation, and spoken languages. DNA was extracted using a phenol-chloroform extraction method for the samples collected from cheek swabs. DNA for the samples collected with the Oragene OG-500 DNA collection kit was extracted at Yale Center for Genomic Analysis. The extracted DNA was then quantified on both a Qubit and Nanodrop. Each sample’s extracted DNA was then diluted to at least 35 ng/ul in a volume of 40 ul and sent to Langebio-Cinvestav sequencing facility in Mexico for SNP genotyping on Illumina’s Multi-Ethnic Global Array.
+ Open protocol
+ Expand
2

Genotyping and Imputation for Traumatic Brain Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotyping was completed at FIMM Technology Center for CENTER-TBI, Cambridge, Turku patients and the Broad Institute for TRACK-TBI, using the Illumina Global Screening Array (GSA-24v2-0 + Multi-Disease). The MGB cohort were genotyped using Illumina's Multi-Ethnic Global array (MEGA) and the pre-releases forms, including MEGA and MEGA-Ex arrays at Illumina at the MGB Translational Genomics Core. A unified quality control procedure was applied for each study cohort and the array-based genotypes were imputed using the Haplotype Reference Consortium16 (link) panel. Details regarding genotyping and imputation are in the Supplementary Methods.
TBI patients’ ancestry were determined by self-reports and confirmed through principal components (PCs) calculated based on the genotypes of the study population combined with the genotypes of the 1000 Genomes17 (link) reference data (Supplementary Methods). The final data set contained 4710 individuals of European ancestry. TRACK-TBI patients clustered to the 1000 Genomes Africans (n = 245) and Admixed Americans (n = 313) ethnic groups were included in the trans-ethnic GWAS meta-analysis, allowing us to constitute a multi-ethnic cohort of 5268 individuals. Target sample size was not defined a priori, but was the largest combined cohort of well-phenotyped patients with outcomes, and DNA that satisfied quality control requirements.
+ Open protocol
+ Expand
3

Multi-Ethnic Genome-Wide Association Analysis Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Affymetrix Axiom® PANAFR array, see https://www.thermofisher.com/order/catalog/product/901788?ICID=search-product; for ClinVar Accession SCV000191187.1, see https://www.ncbi.nlm.nih.gov/clinvar/variation/156804/; for dbGaP, see https://www.ncbi.nlm.nih.gov/gap; for Eugene, see https://genepi.qimr.edu.au/staff/manuelF/eugene/download.html; for GMMAT, see https://content.sph.harvard.edu/xlin/software.html#gmmat; for Illumina Multi-Ethnic Global Array (MEGA), see https://www.illumina.com/science/consortia/human-consortia/multi-ethnic-genotyping-consortium.html; for MetaSoft, see http://genetics.cs.ucla.edu/meta/index.html; for The NHGRI-EBI Catalog of published genome-wide association studies, see https://www.ebi.ac.uk/gwas/; for NCBI Molecular QTL Browser, see https://preview.ncbi.nlm.nih.gov/gap/eqtl/studies/; for OMIM, see http://www.omim.org/; for Sanger Imputation Service, see https://imputation.sanger.ac.uk/.
+ Open protocol
+ Expand
4

Genetic Analysis of Thai METH-MEGA Cohort

Check if the same lab product or an alternative is used in the 5 most similar protocols
Second-stage subjects (N = 3,161; the Thai METH-MEGA sample, Table 1) were recruited from 2015 to 2020 [6 (link)]. DNA samples were genotyped using the Illumina Multi-Ethnic Global Array (MEGA) which includes ~1.78 M SNPs. We removed subjects with sample genotype call rate <0.95, sex mismatch, excess heterozygosity rate, or that were duplicates. SNPs with genotype call rate ≥0.95, or MAF ≥0.01, or HWE p value >10−6 were retained for imputation as with the Thai METH–GSA sample. The same imputation processes and post-imputation quality controls (QC) were applied. We included 794 cases and 1576 alcohol-exposed controls in the association analysis, which used GEMMA and age, sex and the first ten PCs as covariates.
+ Open protocol
+ Expand
5

Genotyping and Quality Control for GWAS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iSAEC samples were genotyped using Illumina HumanOmniExpressExome-8 version 1.0 kit (Illumina, San Diego, CA), which contains ~ 1 million SNPs. The BioVU samples were genotyped using the Illumina Multi-Ethnic Global Array (MEGA; Illumina; ~ 1.7 million SNPs). The other samples were genotyped on Illumina HumanOmni2.5S-8 version 1 (Illumina; ~ 2.5 million SNPs) or Illumina Infinium Global Screening Array version 2 (Illumina; ~ 0.65 million SNPs; Table S2). Quality controls were performed for each of the four datasets separately. SNPs common to all GWAS panels were extracted and the four datasets were then merged. Genotype imputation was performed on the merged dataset using 1000 Genomes phase III version 5 reference panel. The detailed quality control steps for all raw data and the imputation steps were descripted in Supplementary Methods.
+ Open protocol
+ Expand
6

Glaucoma GWAS in Mass General Biobank

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mass General Brigham Biobank (formally known as Partners HealthCare Biobank) is a biorepository of samples from consented patients at Mass General Brigham40 (link) (parent organization of Massachusetts General Hospital and Brigham and Women’s Hospital). In this study, cases were defined based on a diagnosis available on electronic health records, and controls were participants without a recorded diagnosis of glaucoma in their electronic health records. In total, 1,415 glaucoma cases and 18,632 controls were genotyped on an Illumina Multi-Ethnic Global Array (MEGA) (Illumina). Participants showing high rates of missingness or those deemed ancestry outliers from the European ancestry population were removed. Genetic variants with high missingness or extreme allele frequencies were removed before imputation using the HRCr1.1 reference panel (Michigan Imputation server)41 (link). Imputed genotype data in dosage format were used for the analysis. Glaucoma GWAS was conducted using PLINK v.2.00 with a logistic regression model adjusting for age, sex, genetic principal components and genotype batches42 (link).
+ Open protocol
+ Expand
7

Genotyping and Imputation of Large-Scale Genomic Datasets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iSAEC samples were genotyped using Illumina HumanOmniExpressExome‐8 version 1.0 kit (Illumina, San Diego, CA), which contains ~ 1 million SNPs. The BioVU samples were genotyped using the Illumina Multi‐Ethnic Global Array (MEGA; Illumina; ~ 1.7 million SNPs). The other samples were genotyped on Illumina HumanOmni2.5S‐8 version 1 (Illumina; ~ 2.5 million SNPs) or Illumina Infinium Global Screening Array version 2 (Illumina; ~ 0.65 million SNPs; Table S2). Quality controls were performed for each of the four datasets separately. SNPs common to all GWAS panels were extracted and the four datasets were then merged. Genotype imputation was performed on the merged dataset using 1000 Genomes phase III version 5 reference panel. The detailed quality control steps for all raw data and the imputation steps were descripted in Supplementary Methods.
+ Open protocol
+ Expand
8

Admixed Ancestry Genotyping with MEGA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotyping was performed using Illumina’s Multi-Ethnic Global Array (MEGA) that contains SNP sets tailored towards admixed ancestry29 (link). MEGA maximizes coverage and captures the genomic architecture of AA population. Genotypes were called using Genetrain2 algorithm in Illumina Genome Studio software. Genotype data were available for both cases and control individuals over 1.43 million variants.
+ Open protocol
+ Expand
9

Genotyping Quality Control and Filtering

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotyping in GERA was performed on the Affymetric Axion Genotyping System and underwent standard quality control procedures as previously described.8 (link) Subjects in the MGB Biobank were genotyped on the Illumina Multi-Ethnic Global Array (MEGA), Expanded MEGA (MEGA Ex), and MEGA with imputation to the 1000 Genomes phase 3 reference panel using the Michigan Imputation Server.14 (link) Genotyping was performed using the Illumina HumanHap550-Duo and Human 610-Quad BeadChips in the Rotterdam Study. Single-nucleotide polymorphisms (SNPs) with minor allele frequencies<1% and Hardy-Weinberg equilibrium exact test p<10−5 were filtered using Plink V.1.9.15 (link) Identity-by-descent estimates were calculated in each cohort, and one subject from each pair with an identity-by-descent estimate >0.1875 was removed. In GERA, the final dataset comprised 8 995 492 and 9 004 920 variants, respectively, for the OCS burst (online supplemental figure 1) and asthma-related exacerbation (online supplemental figure 2) phenotypes.
+ Open protocol
+ Expand
10

Genotyping and Imputation for Genetic Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genotyping for the AADM study was performed using either the Affymetrix Axiom PANAFR SNP array or the Illumina’s Multi-Ethnic Global Array (MEGA) [31 (link)]. Quality control was performed for each of the arrays separately, resulting in a sample level genotype call rate of at least 0.95 for all samples. For the replication cohorts, genotyping was performed using the Affymetrix Genome-Wide Human SNP Array 6.0 [39 (link)]. For all cohorts, the SNP datasets were filtered for missingness per marker (> 0.05), minor allele frequency (< 0.01), and Hardy-Weinberg equilibrium (P value ≤ 1 × 10−6). Imputation for all cohorts was performed using the African Genome Resources Haplotype Reference Panel via the Sanger imputation Service [40 ]. Quality of imputation was evaluated using INFO scores and only SNPs with INFO scores > 0.3 were retained. After filtering, 18,199,418 variants remained in the final dataset for AADM and 18,093,757 variants for replication cohorts. We checked for population stratification using the “epacts-pca-plot” function in the EPACTS software package (version 3.2.6) [41 ] and identified three significant principal components (PCs) for AADM, one for HUFS, and two for the other replication cohorts [42 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!